Medtronic Comprehensive Income, Including Noncontrolling Interest decreased by 35.8% to $1.10B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 36.0%, from $1.71B to $1.10B.
tmo_comprehensive_income_including_nci| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.04B | $1.48B | $1.65B | $1.26B | $11.00M | $405.00M | $622.00M | $1.21B | $1.26B | $957.00M | $1.44B | $1.71B | $729.00M | $1.71B | $1.10B |
| QoQ Change | — | +42.2% | +10.9% | -23.7% | -99.1% | >999% | +53.6% | +93.9% | +4.2% | -23.9% | +50.4% | +19.0% | -57.4% | +134.0% | -35.8% |
| YoY Change | — | — | — | +20.3% | -99.3% | -75.4% | -50.4% | >999% | +210.4% | +53.9% | +19.3% | +36.2% | -23.8% | +18.6% | -36.0% |